Primitive neuroectodermal tumor (PNET) as second malignancy after treatment of Hodgkin's disease.
Indian J Pediatr
;
2006 May; 73(5): 437-8
Artigo
em Inglês
| IMSEAR
| ID: sea-81149
ABSTRACT
Hodgkin's disease survivors are at an increased risk of developing second malignant neoplasms including secondary bone tumors. Common secondary bone tumors are osteogenic sarcoma and fibrosarcoma. Secondary primitive neuroectodermal tumor is extremely rare in this group. We present below, a rare case of secondary PNET in an 8-year-old child with Hodgkin's disease which developed unusually early outside the radiation portal and discuss potential factors responsible for its causation.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Vimblastina
/
Bleomicina
/
Neoplasias Ósseas
/
Humanos
/
Masculino
/
Doença de Hodgkin
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Doxorrubicina
/
Criança
/
Segunda Neoplasia Primária
Idioma:
Inglês
Revista:
Indian J Pediatr
Ano de publicação:
2006
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS